Randomized clinical trial of a digital medication system to enhance adherence in patients with severe mental disorders

Randomized clinical trial of a digital medication system to enhance adherence in patients with severe mental disorders

To evaluate the effectiveness of a digital medication system in improving adherence among patients with serious mental disorders (SMD), we conducted a cluster-randomized controlled trial across 30 communities in Beijing. Participants, aged 18–65 years, were diagnosed with schizophrenia or bipolar disorder and either received intermittent medication or refused treatment. Recruitment occurred from September 2, 2022, to January 12, 2023. The interv…